Sep 4, 2026
We are pleased to announce that the 21st Japan Endovascular Symposium (JES), chaired by Takao Ohki, M.D., Ph.D., Representative Director and CEO of RIBS, will be held over three days from Friday, August 21 to Sunday, August 23, 2026.
The Japan Endovascular Symposium (JES) is an academic symposium founded by Dr. Ohki in 2006 with the aim of advancing endovascular treatment and improving the quality of medical care. Since its establishment, JES has continued to evolve as a forum for open and candid discussion, covering not only the latest technologies and treatment strategies, but also challenging cases, complications, and lessons learned from unsuccessful outcomes.
Bringing together physicians and researchers from across Japan, JES has grown into one of the leading academic meetings in the field of endovascular treatment. The 20th JES, held in 2025, welcomed more than 1,400 participants, and this year marks the 21st edition of the symposium.
Under the leadership of Dr. Ohki as Chair, the symposium aims to foster in-depth discussion of individual cases and treatment strategies, enabling participants to gain practical insights that can be applied directly to their clinical practice and ultimately contribute to better patient care.
JES has developed into more than an academic meeting. It embodies Dr. Ohki’s belief that “medicine must continue to evolve.” As JES enters its 21st year, this philosophy remains at its core, providing a forum for discussions that will help shape the future of endovascular treatment.
The symposium will also include discussions on the RIBS procedure, which Dr. Ohki has been developing and advancing over the years.
RIBS will continue to pursue the development of innovative medical technologies and contribute to the advancement of healthcare through close engagement with both the clinical and academic communities.
URL：https://www.japanendovascular.com/index.html